We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

MINDRAY In-Vitro Diagnostics

  Gold Mindray offers a range of chemistry and hematology analyzers, designed to meet the needs of smaller labs as a main in... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Mindray's New TE7 Max Ultrasound System Expands Possibilities for Point of Care

By MedImaging International staff writers
Posted on 27 Oct 2021
Print article
Image: Mindray TE7 Max Ultrasound System (Photo courtesy of Mindray)
Image: Mindray TE7 Max Ultrasound System (Photo courtesy of Mindray)

Mindray North America (Mahwah, NJ, USA) has launched its new TE7 Max ultrasound system that maximizes the potential of ultrasound in the Point of Care (POC) market.

The TE7 Max has a 21.5 inch vertically oriented high-definition LED display and a sealed touch-based interface to maximize what clinicians can see. Designed to exceed the requirements of demanding POC environments, the system provides best-in-class image quality and a superior user experience during rapid clinical assessments and procedures. Unlike traditional POC ultrasound machines (POCUS), the TE7 Max provides clinicians with comprehensive and customizable workflow protocols (iWorks™) and an extensive suite of artificial intelligence (AI) powered Smart Tools, all in a compact footprint so they can quickly move from patient-to-patient prioritizing efficiency, reproducibility, and quality for all end-users.

Using AI-powered Smart Tools (Smart B-Line, Smart VTI, Smart IVC), the portable ultrasound system can help assess volume status and fluid responsiveness in critically ill patients. With advanced applications (Smart FHR, Smart Bladder, Auto EF), the TE7 Max can help clinicians during rapid clinical assessments and procedures at patients' bedside or on the go. It is also equipped with the most advanced suite of needle-guidance technologies (eSpacial Navi™ 4D Magnetic Needle Navigation Technology and iNeedle+™) to help streamline workflow and improve accuracy with needle-guided procedures.

The slim cart and large screen beautifully display Mindray's leading-edge technologies and everyday applications that meet the diverse, evolving demands of POC environments. Additionally, the TE7 Max ultrasound machine is backed by Mindray's exclusive Living Technology™ promise that provides customers with easily upgradable software enhancements to secure product investment protection and keep their ultrasound machines at the leading edge of imaging performance excellence throughout the product's life cycle.

"Five years ago, Mindray set a new standard for Point of Care ultrasound with the launch of the TE7," said Maher Elhihi, Mindray's Sr. Director of Marketing, Ultrasound. "That system was truly ahead of its time, and today many of our competitors have tried to emulate. As a leader in Emergency Medicine ultrasound, it is our responsibility to push the technology forward, and the new TE7 Max raises the bar yet again and empowers our customers to provide the highest quality of care now and in the future."

Related Links:
Mindray North America 

Print article
Sun Nuclear



view channel
Image: An AI model can automatically diagnose osteoporosis from hip X-rays (Photo courtesy of Pexels)

Artificial Intelligence (AI) Can Diagnose Osteoporosis from Hip X-Rays

People with osteoporosis, a skeletal disease that thins and weakens bones, are susceptible to fracture associated with bone fragility, resulting in poor quality of life and increased mortality.... Read more


view channel
Image: DWI for detection of locally recurrent pancreatic cancer (Photo courtesy of Pexels)

Adding DWI to Conventional MRI Improves Detection of Locally Recurrent Pancreatic Cancer

A new study has found that adding diffusion-weighted MRI (DWI) to conventional MRI improves the differentiation of locally recurrent tumor and post-surgical fibrosis after pancreatic ductal adenocarcinoma... Read more

Imaging IT

view channel

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: Global diagnostic imaging market is driven by technological advancements (Photo courtesy of Pexels)

Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026

The global diagnostic imaging market is one of the most critical segments of the healthcare sector. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.